Published online Jul 6, 2019. doi: 10.12998/wjcc.v7.i13.1677
Peer-review started: February 15, 2019
First decision: Mach 14, 2019
Revised: April 30, 2019
Accepted: May 10, 2019
Article in press: May 11, 2019
Published online: July 6, 2019
Processing time: 142 Days and 8 Hours
Primary renal synovial sarcoma (PRSS) is an extremely rare tumor with a poor prognosis. Its imaging and immunohistochemical characteristics may overlap with other renal tumors, which renders its early diagnosis in a dilemma. The diagnosis of primary renal synovial sarcoma requires histopathology and the confirmation of SYT-SSX gene fusion using molecular techniques. Cases of primary renal synovial sarcoma have been previously reported in the literature. However, to our knowledge, primary renal allograft synovial sarcoma was never described.
A 43-year-old male patient who underwent kidney transplantation 9 months ago came to our hospital for regular follow-up. Traditional ultrasonography revealed multiple hypo-echo neoplasms in the renal allograft. Contrast-enhanced computed tomography (CECT) showed slightly hyper-density masses with slow homogeneous enhancement. Ultrasound-guided biopsy was conducted for accurate pathological diagnosis. The neoplasms were diagnosed as synovial sarcoma by pathological, immunohistochemical, and genetic analyses. Positron emission tomography/CT showed no evidence of metastasis. At approximately one week post biopsy, contrast-enhanced ultrasound was conducted to eliminate active hemorrhage. One month later, CECT showed that the biggest neoplasm grew from 3.3 cm to 5.7 cm in diameter. Parametric imaging was conducted with SonoLiver CAP to conduct further quantitative analysis, which showed that the enhancement pattern was heterogeneous hyper-vascular enhancement. Radical surgical resection of the whole renal allograft and ureter was conducted without additional adjuvant chemotherapy or external radiotherapy. Anlotinib was chosen for targeted therapy with a good response.
We propose multimodality imaging for accurate diagnosis of renal allograft synovial sarcoma especially when it is formed by spindle-shaped cells.
Core tip: Primary renal synovial sarcoma is an extremely rare tumor with a poor prognosis. We present the multimodality imaging characteristics of primary renal allograft synovial sarcoma in a 43-year-old male patient, which manifested as new hypo-echo solid neoplasms on ultrasonography or cystic-like neoplasms on contrast-enhanced computed tomography. After an accurate diagnosis was made, radical allograft nephrectomy was done without additional adjuvant chemotherapy or external radiotherapy. Anlotinib was chosen for targeted therapy. This case highlights the importance of multimodality imaging for early accurate diagnosis of renal allograft synovial sarcoma, especially when it is formed by spindle-shaped cells.